Items tagged with Access

Civil society groups issue appeal to medicines regulators and governments (post with simple image)

Civil society groups appeal to medicines regulators and governments on the occasion of the 17th International Conference of Drug Regulatory Authorities.

Leave no one behind: Stop TB Partnership launches two new briefs on vulnerable groups (post with simple image)

14 December 2016 - Geneva, Switzerland - The Stop TB Partnership today launched two new briefs on TB vulnerable populations, focusing on health care workers, and on PLHIV.

MSF calls on Johnson & Johnson to improve access to bedaquiline (post with simple image)

Médecins Sans Frontières (MSF) urges Johnson & Johnson to ensure widespread access to bedaquiline for the treatment of multidrug-resistant TB.

Advocates call for the Philippines Food and Drug Administration to register delamanid (post with simple image)

TB advocates encourage the Philippines Food and Drug Administration to approve delamanid, an important treatment option for people with multidrug-resistant TB.

Advocates call on the Indian Prime Minister to ensure availability of new TB drugs to combat drug-resistant TB (post with simple image)

Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.

Health groups call on Indian Government to urgently make life-saving TB drug available (post with simple image)

Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.

Advocates maintain pressure on the Ministry of Health to facilitate access to delamanid in Peru (post with simple image)

TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.

Advocates encourage the health authorities in Peru to approve the endTB study (post with simple image)

TB advocates stress the importance of the observational endTB study for expanding access to new treatments for multidrug-resistant TB in Peru.

Fewer than 5% of people in need are treated with new TB drugs, nearly four years after their approval (post with simple image)

Companies and countries must take urgent action to increase access to these life-saving treatments.

Advocates call on Otsuka to ensure access to delamanid in South Africa (post with simple image)

TB advocates urge Otsuka to provide sufficient and sustainable access to delamanid for the treatment of drug-resistant TB in South Africa.

Page 46 of 47 · Total posts: 0

←First 45 46 47 Last→